Author:
Vajjha Soujanya,Bommuluri Vijay,Rumalla Chidananda Swamy,Kaliyaperumal Muralidharan,Korupolu Raghu Babu,chopella Vidyasagar
Reference18 articles.
1. Quigley EM, Fried M, Gwee KA, Khalif I, Hungin AP, Lindberg G, Abbas Z, Fernandez LB, Bhatia SJ, Schmulson M, Olano C, LeMair A; Review Team: World Gastroenterology Organisation. Irritable bowel syndrome: a global perspective. Journal of Clinical Gastroenterology, Oct 2016, 50(9), 704–713.
2. Lauren Peyton, PharmD, CDE and Joy Greene, PharmD Irritable Bowel Syndrome: Current and Emerging Treatment Options. Pharmacy and Therapeutics, 2014 Aug; 39(8): 567-572,578.
3. Emerging treatments in neurogastroenterology: eluxadoline - a new therapeutic option for diarrhea-predominant IBS;Lacy;Neurogastroenterol. Motil.,2016
4. End points in irritable bowel syndrome;Mangel;Gastroenterol. Res.,2011
5. Center for Drug Evaluation and Research. Guidance for industry: irritable bowel syndrome—clinical evaluation of drugs for treatment. May, 2012.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献